Leerink Swann

Related by string. * : Leerink Swann analyst . Leerink . Leerink Swan . Leerink Swan analyst . Leerink analyst . A. Leerink / Swanner . swanning . swanned . SWANN . Swanns . Swanning : Stuart Broad Graeme Swann . spinners Graeme Swann . Lynn Swann . Isaiah Swann . Elizabeth Swann Keira . Ryan Sidebottom Graeme Swann . Tim Bresnan Graeme Swann . spinner Graeme Swann * Leerink Swann LLC *

Related by context. All words. (Click for frequent words.) 67 Leerink Swann analyst 67 Leerink 65 Leerink Swan 64 CE Unterberg Towbin 62 analyst Bruce Cranna 62 SG Cowen 62 Bruce Cranna 62 analyst Amit Hazan 62 Piper Jaffray 60 Merriman Curhan Ford 59 Stifel Nicolaus 59 ThinkEquity Partners LLC 59 Brean Murray Carret 59 Pacific Growth Equities 58 Leerink Swan analyst 58 WR Hambrecht 58 Ladenburg Thalmann 58 Mark Monane 57 Adams Harkness 57 Lazard Capital Markets 57 & Renshaw 57 W. Baird 56 analyst Jonathan Aschoff 56 Cochran Caronia 56 Suntrust Robinson Humphrey 56 Thomas Weisel Partners 56 MEDACorp 56 analyst Geoffrey Meacham 56 Jason Gurda 56 Leerink Swann LLC 56 Trevor Polischuk 56 Monness Crespi Hardt 56 JMP Securities 56 Annabel Samimy 56 Lazard Capital 56 Jefferies 55 Brean Murray 55 Punk Ziegel 55 ANALYST TAKE Jefferies 55 JMP Securities LLC 55 Phil Nalbone 55 Eric Ende 54 Canaccord Adams 54 analyst Seamus Fernandez 54 analyst Lawrence Keusch 54 Joel Sendek 54 analyst Mark Monane 54 analyst Glenn Novarro 54 Piper Jaffray PJC 54 Friedman Billings Ramsey 54 Joshua Schimmer 54 Avik Roy 53 Thomas Weisel 53 Cochran Caronia Waller 53 SG Cowen Securities 53 Isaac Ro 53 Monane 53 ANALYST TAKE Stifel Nicolaus 53 Gerard Klauer Mattison 53 Tenthoff 53 analyst Jim Reddoch 53 WR Hambrecht + 53 ThinkEquity LLC 53 Jon LeCroy 53 ThinkEquity 53 Jefferies NYSE JEF 53 analyst Randall Stanicky 53 Ken Cacciatore 53 analyst Geoffrey Porges 53 Larry Biegelsen 53 CE Unterberg 53 Canaccord Genuity 52 analyst Robert Cihra 52 Steven Harr 52 Mark Schoenebaum 52 Wedbush 52 Raj Denhoy 52 Caris & 52 Quynh Pham 52 Ladenburg Thalman 52 Jason Kantor 52 Pantginis 52 Ardour Capital 52 Jonathan Aschoff 52 LifeTech Capital 52 CK Cooper 51 analyst Mark Schoenebaum 51 Broadpoint Capital 51 Freidman Billings Ramsey 51 Geoff Porges 51 Cory Kasimov 51 Morgan Joseph TriArtisan 51 Bret Holley 51 Geoffrey Meacham 51 Citi Investment 51 Dhulsini de Zoysa 51 ThinkEquity Partners 51 Auriga USA 51 Capstone Investments 51 OrbiMed Advisors 51 Eric Coldwell 51 analyst Jami Rubin 51 Janney Montgomery Scott 51 Natexis Bleichroeder 51 Jason Kolbert 51 Sanford Bernstein 51 Aaron Reames 51 Stifel Nicholaus 51 David Amsellem 51 Craig Hallum Capital 50 Dr. Jim Birchenough 50 Olav Zilian 50 analyst Yaron Werber 50 Unterberg Towbin 50 Fox Pitt Kelton 50 Yaron Werber 50 Sanford C. Bernstein 50 Tullis Dickerson 50 Sara Michelmore 50 Jami Rubin 50 Natixis Bleichroeder 50 Adam Klauber 50 RW Baird 50 Ziopharm 50 Kalpesh Kapadia 50 Bert Hazlett 50 Lauren Cooks Levitan 50 Sidoti & 50 FTN Midwest 50 Stanicky 50 Jerry Doctrow 50 Akhtar Samad 50 Jeffrey Frelick 50 Lawrence Keusch 50 Joseph Pantginis 50 JoAnne Feeney 50 Brigantine Advisors 50 Joanne Wuensch 50 Stifel Nicholas 50 Piper Jaffray Cos. 50 Howe Barnes Hoefer 49 OrbiMed Advisors LLC 49 NASDAQ ARIA 49 Dr. Joshua Schimmer 49 analyst Liana Moussatos 49 Piper Jaffrey 49 Khandaker Partners 49 GARP Research 49 JP Morgan 49 Renshaw 9th 49 A. Leerink 49 Keay Nakae 49 Liana Moussatos 49 HC Wainwright 49 ANALYST TAKE Bear Stearns 49 Ardour Capital Investments 49 NASDAQ SLXP 49 Eli Lilly NYSE LLY 49 Sterne Agee 49 Sandler O'Neill 49 George Grofik 49 Peter Goldmacher 49 Steven Burakoff 49 analyst Raj Denhoy 49 Edward Tenthoff 49 Piper Jaffray analyst 49 Tao Levy 49 OrbiMed 49 Bryan Garnier 49 J.P. Morgan Healthcare 49 Auxilium Pharmaceuticals 49 Feltl 49 Nasdaq IDIX 49 PiperJaffray analyst 49 Synta Pharmaceuticals 49 RBC Capital Markets 49 analyst Gbola Amusa 48 Helvea 48 Boenning & 48 Needham Biotechnology 48 BioCentury Future Leaders 48 Feltl & 48 Merrill Lynch OOTC MERIZ 48 Rexahn Pharmaceuticals 48 Weikang Bio Technology 48 Glenn Reicin 48 Dahlman Rose 48 Shiv Kapoor 48 Prudential Equity 48 Shattuck Hammond 48 Josephthal 48 analyst Ajit Pai 48 BioCentury NewsMakers 48 Miller Tabek 48 Stelios Papadopoulos 48 Oppenheimer 48 Les Funtleyder 48 HealthCare Ventures 48 Ventrus Biosciences 48 Karl Heinz Koch 48 analyst Joanne Wuensch 48 ONXX 48 Eun K. 48 Eyetech Pharmaceuticals 48 Nasdaq ANDS announced 48 Gary Nachman 48 Punk Ziegel analyst 48 analyst Bruce Nudell 48 Morgan Stanley 48 NASDAQ SLXP today 48 RW Baird analyst 48 BIO InvestorForum 48 Robinson Humphrey 48 Andrew Vaino 48 Chris Shibutani 48 Optimer Pharmaceuticals 48 Orbimed Advisors LLC 48 PiperJaffray 47 WBB Securities 47 Darren Lehrich 47 ThinkPanmure 47 Michael Krensavage 47 MedPanel 47 FBR Capital Markets 47 Douglas Sipkin 47 JMP Securities analyst 47 analyst Jim Birchenough 47 Nasdaq ONXX 47 Scott Mushkin 47 Keefe Bruyette & 47 Panmure Gordon 47 Ladenburg Thalmann analyst 47 Geoffrey Porges 47 JB Hanauer 47 CapStone Investments 47 NASDAQ ENDP 47 BioMimetic Therapeutics Inc. 47 David Molowa 47 Chardan Capital Markets 47 Moussatos 47 analyst Cory Kasimov 47 Regeneron Pharma 47 Oppenheimer OPY 47 BIO Investor 47 Punk Ziegel & 47 BMO Capital 47 Seamus Fernandez 47 NYSE Amex LTS 47 Xenoport Inc. 47 Dahlman Rose & 47 Denhoy 47 Idenix Pharmaceuticals 47 Sandler O'Neil 47 Wedbush Securities 47 Idenix Pharmaceuticals Inc. 47 analyst Kristine Koerber 47 Caris 47 Guy Moszkowski 47 Nasdaq ADLR 47 analyst Emme Kozloff 47 CapStone 47 Muken 47 Stryker NYSE SYK 47 Matthew Borsch 47 ROTH Capital Partners 47 Analyst Cai von 47 Affymax AFFY 47 Craig Hallum 47 Therapeutic Competitors 47 Bristol Myers BMY 47 Shinyoung Securities 47 analyst Sapna Srivastava 47 Mark Bacurin 47 Palatin Technologies 47 Sagent 47 Inhibitex INHX 47 Louis Miscioscia 47 MDB Capital Group 47 Nasdaq OSCI 46 Navdeep Jaikaria 46 analyst Edwin Mok 46 Wachovia Capital Markets 46 Ardea Biosciences 46 FIG Partners 46 SoundView 46 Batlivala & 46 Randall Stanicky 46 Equity Capital Markets 46 Ian Somaiya 46 Krystexxa 46 Sciele Pharma 46 Putnam Lovell NBF 46 Nasdaq AVNR 46 Wachovia Securities 46 Jim Reddoch 46 Steve Shubitz 46 Funtleyder 46 Sipkin 46 Vertex Pharmaceuticals NASDAQ VRTX 46 TSRX 46 Encysive Pharmaceuticals 46 analyst Jason Gurda 46 Doug Sipkin 46 Seattle Genetics SGEN 46 AMAG Pharmaceuticals Inc. 46 Wedbush analyst 46 Kemp Dolliver 46 analyst Andrey Glukhov 46 James Kumpel 46 MPM Capital 46 analyst Kemp Dolliver 46 Kaufman Brothers 46 Nasdaq INCY announced 46 Ariad Pharmaceuticals 46 reaffirmed Outperform rating 46 sole bookrunning manager 46 Geoff Meacham 46 Nasdaq EXAS today 46 HealthCor 46 Cannacord Genuity 46 Broadpoint.Gleacher 46 FTN Midwest Securities 46 Nasdaq MERR 46 Krensavage 46 Creditsights 46 ThinkPanmure LLC 46 analyst Christa Quarles 46 Broadpoint.AmTech analyst 46 Randal Konik 46 Inc. AMEX LTS 46 Lexicon Pharmaceuticals 46 Brozak 46 Anadys Pharmaceuticals Inc. 46 Boenning 46 Canaccord 46 Birgit Kulhoff 46 Gbola Amusa 46 SunTrust Robinson 46 Deane Dray 46 NASDAQ QCOR 46 ImmunoCellular Therapeutics 46 NASDAQ ONXX 46 Ken Trbovich 46 Jefferies Broadview 46 reaffirmed Market Perform 46 BioSphere Medical 46 firm Aite Group 46 analyst Ken Trbovich 46 Saftlas 46 BMRN 46 Kochnover 46 OPKO Health 46 Karl Heinz Scheunemann 46 Barry Tarasoff 46 John Calcagnini 46 analyst Colby Synesael 46 Investment Banking 46 Stifel 46 Cannacord Adams 45 OPKO 45 analyst Amit Bhalla 45 analyst Randal Konik 45 Nasdaq SLXP 45 Nasdaq ANDS 45 Catalyst Biosciences 45 Leerink analyst 45 Acorda Therapeutics ACOR 45 JMP Securities JMP 45 Celgene CELG 45 Matt DiFrisco 45 analyst Les Funtleyder 45 Merrill Lynch 45 Endo Pharmaceuticals NASDAQ ENDP 45 Singular Research 45 Windhover Information Inc. 45 Bristol Myers NYSE BMY 45 analyst Tore Svanberg 45 Rexahn Pharmaceuticals Inc. 45 ImmunoCellular 45 BMO Capital Markets 45 Dificid 45 Canaccord Adams Hepatitis C 45 Troy Mastin 45 Sepracor SEPR 45 Oscar Gruss 45 Friedman Billings 45 NASDAQ SOMX specialty 45 Roger Longman 45 Edwin Groshans 45 JPMorgan Basics 45 Auxilium Pharma 45 Alnara Pharmaceuticals 45 Y. Edwin Mok 45 Tom Cholnoky 45 NASDAQ VRTX 45 Cypress Bioscience 45 denosumab 45 Helene Wolk 45 Miller Tabak 45 Sandler O'Neill + 45 NYSE JPM PRK NYSE 45 Ross Muken 45 Northland Capital Markets 45 analyst Maged Shenouda 45 KeyBanc Capital Markets 45 Daniel Fannon 45 JB Hanauer & 45 Gleacher 45 analyst Glenn Reicin 45 NYSE JEF 45 David Turkaly 45 Nollenberger Capital 45 TripleTree 45 www.piperjaffray.com 45 analyst Sara Michelmore 45 Stifel Nicolaus Weisel 45 Nasdaq MOGN 45 Tianyin Pharmaceutical 45 CJS Securities 45 KBW 45 Crowell Weedon & 45 FBR Capital NASDAQ FBCM 45 Brad Reback 45 Suraj Kalia 45 Delafield Hambrecht 45 Amylin AMLN 45 Capital Markets Janney Montgomery 45 Brion Tanous 45 Roopesh Patel 45 Mike Krensavage 45 Specialty Pharmaceutical 45 Questcor Pharmaceuticals 45 Sven Borho partner 45 Morgan Keegan 45 William Tanona 45 NASDAQ ADLR 45 Nasdaq DNDN 45 SVLS 45 RBC Capital 45 Swiss brokerage Helvea 45 Peter Nesvold 45 Biegelsen 45 Putnam Lovell 45 Dale Pfost 45 analyst Charles Boorady 45 ANALYST TAKE JPMorgan 45 Hana Daetoo Securities 45 analyst Rommel Dionisio 45 Ananda Baruah 45 Cubist Pharmaceuticals Inc. 45 analyst William Tanona 45 Express Scripts NASDAQ ESRX 45 NASDAQ BMTI 45 Glenn Novarro 45 Bancorp Piper Jaffray 45 NASDAQ AUXL 45 FoxHollow Technologies 45 Fulcrum Global Partners 45 Acumen BioFin Rodman 45 Tudor Pickering 45 BernsteinResearch 45 ZIOPHARM Oncology Inc. 45 Tanona 45 Daniel Berenbaum 45 analyst Larry Biegelsen 45 SMH Capital 45 Cubicin 45 Rob Cihra 44 Ajit Pai 44 sole bookrunning 44 Aderis 44 Questcor Pharmaceuticals Inc. 44 Inc. Nasdaq GLCH 44 Brian Bapty 44 Ralph Giacobbe 44 Aite Group LLC 44 Joel Fishbein 44 Ehrenkrantz King Nussbaum 44 TranS1 44 ZIOPHARM Oncology 44 CR Bard BCR 44 Charles Boorady 44 Simos Simeonidis 44 Becton Dickinson BDX 44 Pluristem Therapeutics 44 Needham 44 Vion Pharmaceuticals 44 Analyst Tristan Gerra 44 Institutional Fixed Income 44 Nasdaq SOMX 44 Kin Ho 44 AVEO Pharmaceuticals 44 Hainan Helpson Medical 44 Tufts CSDD 44 analyst Youssef Squali 44 Salmedix 44 Janney Montgomery 44 Sunesis Pharmaceuticals 44 Hapoalim Securities 44 JPMorgan 44 James NYSE RJF 44 Mr. Bentsur 44 Nasdaq GPRO announced 44 Resumes Coverage 44 Biomarin 44 Simeonidis 44 JMP Securities Research 44 NASDAQ AFFY 44 C. Bernstein 44 Keefe Bruyette 44 Daniel Junius 44 Wunderlich Securities 44 COWN 44 Apricus Biosciences 44 consultancy Booz 44 Anadys Pharmaceuticals 44 Cubist Pharma 44 Jeffrey Holford 44 Molowa 44 Chris Umiastowski 44 RBC Capital NYSE RY 44 Jon Lecroy 44 Justin Sebastiano 44 Elemer Piros 44 Glenn Schorr 44 P. Klinefelter 44 Frozen Shoulder syndrome 44 Dendreon 44 Peer Perform rating 44 William Plovanic 44 Celgene Revlimid 44 SoundView Technology Group 44 Richard Kugele 44 Evercore Partners EVR 44 Dynavax Technologies 44 Gabelli 44 Liisa Bayko 44 bookrunning manager 44 Scientia Advisors 44 Sena Lund 44 ThinkEquity downgraded 44 Piper Jaffray Reiterates 44 Schwab Soundview 44 Altus Pharmaceuticals 44 Anti Infectives 44 William F. Tanona 44 Joe Pantginis 44 Dave Shove 44 Agile Therapeutics 44 ICOS Corporation 44 Andrew Goodsall 44 Vertex Pharmaceuticals VRTX 44 Tee Sze Chiah 44 analyst Tim Klasell 44 Schwab Capital Markets 44 Merriman Curhan 44 Newbury Piret 44 Cerimon 44 Canaccord Adams analyst 44 Cai von Rumohr 44 Morgan Stanely 44 Moshe Katri 44 Global Healthcare Unplugged 44 Idenix 44 Luke Evnin 44 Susquehanna Financial 44 Keryx 44 NASDAQ ZIOP 44 D.A. Davidson 44 Steven Alexopoulos 44 Nasdaq IMGN 44 WR Hambrecht analyst 44 Eyetech 44 THE SPARK Jefferies 44 Keusch 44 Elan Tysabri 44 Grofik 44 #th Annual J.P. 44 PCRX 44 Advest 44 Adolor Corporation 44 analyst Simos Simeonidis 44 Therapeutics Roundtable 44 FAF Advisors 44 ROTH Capital 44 BNY Capital Markets 44 Reynders Gray 44 Analyst Toni Sacconaghi 44 Canaccord Genuity Cardiovascular 44 CombinatoRx Incorporated NASDAQ CRXX 44 Matthew Kather 44 analyst Shebly Seyrafi 44 Matthew Heimermann 44 Celgene NASDAQ CELG 44 inVentiv 44 ThinkEquity analyst 44 Canaccord Genuity Growth 44 RF Lafferty 44 Kaufman Bros 44 NGM Biopharmaceuticals 44 Amgen denosumab 44 ARYx Therapeutics Inc. 44 Carla Antunes da Silva 44 Endo Pharma 44 Clarus Securities 44 Penwest Pharmaceuticals 44 SSRX 44 Dendreon Provenge 44 Hana Biosciences 44 Nasdaq VRTX today 43 Nasdaq VRTX 43 Portales Partners 43 Clarus Ventures 43 addressing idiopathic pulmonary 43 KeyBanc 43 Rachael Rothman 43 Onyx Pharma 43 analyst Ashwin Shirvaikar 43 analyst Peter Misek 43 ANALYST TAKE Merrill Lynch 43 AcelRx Pharmaceuticals 43 Rajeev Chand 43 Tudor Pickering Holt 43 Guotai Jun'an Securities 43 analyst Patrick Walravens 43 Piper Jaffray nyse PJC 43 JMP Securities Healthcare 43 analyst Shaul Eyal 43 NASDAQ MOGN 43 Nasdaq AUXL 43 Broadpoint Amtech 43 Pancari 43 Alex Rygiel 43 NASDAQ REGN 43 Yakatan 43 Eighth Annual JMP 43 Sinopac Securities 43 Essex Woodlands 43 Credit Suisse 43 Stifel Nicolaus analyst 43 Nasdaq INCY 43 Maynard Um 43 BofA Merrill 43 Equal Weight rating 43 Taglich Brothers 43 Arena Pharmaceuticals ARNA 43 analyst Dan Wantrobski 43 Merrill Lynch Tradebot 43 Intarcia 43 Merck boceprevir 43 Oxis International 43 PharmaVitae Profile 43 Andrew Speller 43 Ramon Llamas IDC 43 Inc JEF JEF 43 Polymeropoulos 43 NeurAxon Inc. 43 Oppenheimer NYSE OPY 43 Genitope Corporation 43 biopharmaceuticals 43 MultiCell Technologies 43 J. Quilty 43 Diasome 43 Brigantine Advisors analyst 43 analyst Richard Kugele 43 NuVasive NUVA 43 NLV Partners 43 orthopedic implant maker 43 Banc 43 Marco Mak 43 BancAnalysts Association 43 Nasdaq CBST 43 Rigel Pharmaceuticals 43 analyst Tavis McCourt 43 Lombard Odier Darier Hentsch 43 Darashaw 43 Medica Venture Partners 43 analyst Anthony Chukumba 43 Nicholas Landekic 43 China Nuokang Bio 43 Stacy Rasgon 43 Eric Kainer 43 Synergy Pharmaceuticals 43 Group Inc JEF.N 43 analyst Bijan Moazami 43 Oxigene 43 Cormark Securities 43 Nasdaq MEDI 43 Incyte INCY 43 Westwind Partners 43 United Therapeutics UTHR 43 NASDAQ ANDS 43 Coffina 43 Smid Cap Conference 43 Katherine Egbert 43 Mindray Medical 43 Argolyn 43 Progenics Pharmaceuticals 43 Paramount BioSciences 43 FOXH 43 NASDAQ IPXL today 43 Avila Therapeutics 43 analyst Vivek Juneja 43 Claude Camire 43 Neostem 43 OGXI 43 NovaBay Pharmaceuticals 43 Medivation Inc 43 BIOCOM Investor Conference 43 Tobias Levkovich 43 Gilead Sciences nasdaq GILD 43 Brian Gesuale 43 Aimee Marcel Remey 43 Sopherion Therapeutics 43 April Scee 43 Sciele Pharma Inc. 43 Opko Health 43 Supavud Saicheua 43 Langen McAlenney 43 MR Beal 43 Nasdaq QCOR 43 Bear Stearns 43 Cougar Biotechnology 43 Outperform rating 43 Lehman Brothers Eleventh 43 Holger Blum 43 reaffirmed Neutral 43 +#-#-#-# @ russopartnersllc.com 43 Aegerion Pharmaceuticals 43 Ken Zerbe 43 Siebert Brandford Shank 43 Celent Communications 43 Cowen 43 Cyclacel Pharmaceuticals 43 Jim Birchenough 43 Nasdaq IPXL 43 CEOs Unplugged 43 Greystone Associates 43 Akesis Pharmaceuticals 43 Global Industrials 43 Knall Cohen Group 43 CIBC World 43 Small Cap Ideas 43 Bruce Nudell 43 SIGnificant Investment Options 43 analyst Alex Gauna 43 Avanir 43 Altman Vilandrie & 43 Amgen Vectibix 43 Inc. NASDAQ HITK 43 Hulk Caris & 43 analyst Jason Napodano 43 IDFC SSKI 43 Ronny Gal 43 Nick Selvaratnam 43 BioMimetic Therapeutics NASDAQ BMTI 43 analyst Joseph Altobello 43 Tad Piper 43 Good Morning Shinhan 43 Amylin Eli Lilly 43 AG Edwards 43 Gilead Sciences Inc 43 Salix Pharmaceuticals Ltd 43 analyst Guy Moszkowski 43 Credit Suisse First 43 Endo Pharmaceuticals ENDP 43 B. Nemeroff 43 PRH NYSE JPM PRX 43 China Aoxing Pharmaceutical 43 BoA Merrill Lynch 43 Broadpoint Gleacher 43 Ragen MacKenzie 43 Loomis Sayles 43 JMP Securities downgraded 43 ImmunoGen IMGN 43 analyst Brad Hintz 43 Jonathan Ruykhaver 43 Healthcare Tailwinds 43 Jeff Wlodarczak 43 Reiterates Hold 43 Reik Read 43 Optimer 43 PDGI 43 Ascenta Therapeutics 43 AR Schmeidler & 43 Ardea Biosciences Inc. 43 Gene Munster Piper Jaffray 43 analyst Mark Lipacis 43 Curagen 43 Thoratec Presentation 43 ANALYST TAKE Goldman Sachs 43 Karen Boodram 43 Marc Cluzel 43 Ninth Annual JMP 43 Cantor Fitzgerald reiterates 43 John DiFucci 43 Poniard 43 FBR Capital Upgrades 43 A. Sasa Zorovic 43 PrinceRidge 42 Standpoint Research 42 Vertex VRTX 42 Leiden MD Ph.D. 42 Cornerstone Therapeutics 42 Auxilium Pharmaceuticals Inc 42 IDIX 42 Nuedexta 42 BioRexis 42 Barry Labinger 42 BioSante Pharmaceuticals NASDAQ BPAX 42 XenoPort NASDAQ XNPT 42 Fixed Income Strategist 42 NASDAQ AMAG 42 Ironwood Pharmaceuticals 42 Analyst Cody Acree 42 Jesse Pichel 42 Reiterates Outperform 42 Nasdaq CADX 42 Keybanc 42 Ewing Bemiss & 42 Intermune 42 Biotech Industry 42 Healthcare Tailwinds Conference 42 Reiterates Neutral Rating 42 Chief Investment Strategist 42 BioVex 42 Barrons.com 42 Moelis & 42 KTB Securities 42 Proteolix 42 InteKrin 42 BGB Securities 42 Goldman Sachs 42 Depomed NASDAQ DEPO 42 Yair Reiner 42 Daniel Renouard 42 NYSE Amex RNN 42 Richard X. Bove 42 analyst Albert Savastano 42 Jefferies Quarterdeck division 42 Liprotamase 42 OneMedForum 42 Aite Group 42 AMEX QSC 42 Aflibercept 42 analyst Jesse Pichel 42 SEB Enskilda 42 Kaufman Bros. 42 Urigen Pharmaceuticals 42 Anika Therapeutics 42 NASDAQ GPRO 42 Michael Vinciquerra 42 ADVENTRX Pharmaceuticals 42 Andrew Kligerman 42 ZIOP 42 Second Annual SIGnificant 42 BAS ML 42 Arcalyst 42 Biomarin Pharm 42 fibrosis IPF 42 UOB KayHian 42 ABN AMRO Incorporated 42 MedPredict 42 NASDAQ CBST 42 David Hochstim 42 Rodman Renshaw 42 Paradigm Capital 42 Jed Dorsheimer 42 Jeremy Sussman 42 Napodano 42 Canaccord Adams Healthy Living 42 Jefferies JEF 42 Lazard Freres & 42 Remi Barbier 42 analyst Cai von 42 Knight Libertas LLC 42 Stifel Nicolas 42 VRTX 42 FTN Equity Capital Markets 42 TransMolecular 42 Cordis Corporation Johnson 42 Barrie Cornes 42 analyst Tim Savageaux 42 firm Celent 42 Ladenburg Thalmann Financial 42 Phillip Nalbone 42 analyst Phillip Nalbone 42 Inc. NASDAQ ACOR 42 Critical Therapeutics 42 DPP4 inhibitor 42 Aegerion Pharmaceuticals Inc. 42 Reiterates Buy 42 Wedbush Morgan Securities 42 Valeant Pharmaceuticals NYSE VRX 42 Artio Global Investors 42 Sandler O'Neill Partners LP 42 analyst Mark Wiltamuth 42 Joe Giamichael 42 NASDAQ BPAX 42 Ironwood Pharmaceuticals Inc. 42 Nasdaq ZIOP 42 Ittai Kidron 42 Nicholas Aberle 42 Nasdaq NPSP 42 Inc. NASDAQ VVUS 42 analyst Douglas Sipkin 42 CE Unterberg Towbin Emerging 42 Tisco Securities 42 Tellabs Presentation 42 Muraglitazar 42 ICON plc 42 analyst Ananda Baruah 42 BioCentury Newsmakers 42 Barclays Capital Reiterate Overweight 42 Syndicate Prospectus Department 42 Biodefense Vaccines 42 Bayhill Therapeutics 42 O'Shaughnessy Asset Management 42 Inc. Nasdaq IMGN 42 OneMedPlace 42 BioTrends 42 Threshold Pharmaceuticals Inc. 42 Auxilium Pharmaceuticals AUXL 42 Richard Fetyko 42 told BioWorld Today 42 Insituform Technologies INSU 42 NASDAQ KERX 42 Surface Logix 42 Piper Jaffray reiterates 42 Axcan Pharma 42 Francois Trahan 42 Broadpoint Gleacher Securities 42 McKesson MCK 42 JP Morgan SMid Cap 42 Millennium Velcade 42 Therapeutic Competitors companiesandmarkets.com adEgemonye 42 Ambrian Partners 42 Vivus Qnexa 42 Vertex telaprevir 42 & Renshaw Techvest 42 Medicis NYSE MRX 42 Nasdaq LXRX 42 Pfizer Sutent 42 Wells Fargo Initiates Coverage 42 analyst Steven Wieczynski 42 Inc JEF 42 Enzon Pharmaceuticals Inc 42 analyst Dick Bove 42 Calyon Securities analyst 42 BioMedTracker 42 Tranzyme 42 ImClone Erbitux 42 Nasdaq SSRX 42 Nasdaq REGN 42 Gilead Sciences NASDAQ GILD 42 ANALYST TAKE Deutsche 42 Co. Incorporated Attn 42 Bear Stearns SMid Cap 42 Genentech Herceptin 42 Amgen Prolia 42 Maintains Outperform 42 analyst Greg Mesniaeff 42 analyst Lori Appelbaum 42 LMAT 42 Adventrx 42 Ception Therapeutics 42 Archemix Corp. 42 Nils Larsen Tribune 42 Andrew Garthwaite 42 Nasdaq ISTA 42 Shedlarz 42 NASDAQ DCTH 42 Satya Chillara 42 Corgentech 42 Dick Bove 42 CeNeRx BioPharma 42 Inc. NASDAQ HGSI 42 Inc. Nasdaq VRUS 42 UBS Warburg 42 DiObex 42 Outperform Rating 42 Teva Pharmaceutical TEVA 42 consultancy Celent 42 Two Upcoming Investor 42 plc NASDAQ AMRN 42 JMP Group 42 NASDAQ IMGN 42 Two Upcoming Conferences 42 TriPoint Global Research 42 Legg Mason Wood 42 Cordis Cardiology 42 Reiterates Buy Rating 42 Allos Therapeutics Incorporated 42 AMEX AIS 42 BioDelivery Sciences 42 AMEX RGN 42 Angiotech Pharmaceuticals 42 Lawrence Biegelsen 42 Lead Bookrunning Manager

Back to home page